These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7295478)

  • 41. Is Taurolidine a candidate for treatment of rheumatoid arthritis?
    Marcinkiewicz J; Głuszko P; Kontny E; Kwaśny-Krochin B; Bobek M; Wierzchowski W; Ciszek M; Maśliński W
    Clin Exp Rheumatol; 2007; 25(2):211-8. PubMed ID: 17543144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antimicrobial actions of taurolin and other preparations on the pathogenic spectrum in dentoalveolar infections.
    Zimmermann M; Preac-Mursic V
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):130-6. PubMed ID: 8468110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to Olthof et al.
    Klek S; Szczepanek K
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385-6. PubMed ID: 25883236
    [No Abstract]   [Full Text] [Related]  

  • 44. C controlled trial of taurolin in established bacterial peritonitis.
    Browne MK; MacKenzie M; Doyle PJ
    Surg Gynecol Obstet; 1978 May; 146(5):721-4. PubMed ID: 347606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms.
    Zimmermann M; Preac-Mursic V
    Arzneimittelforschung; 1992 Sep; 42(9):1157-9. PubMed ID: 1445486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent catheter related bloodstream infections by Candida glabrata: successful treatment with taurolidine.
    Diamanti A; Capriati T; Iacono A
    Clin Nutr; 2014 Apr; 33(2):367. PubMed ID: 24485770
    [No Abstract]   [Full Text] [Related]  

  • 47. Do we know the benefits of a taurolidine lock in adult home parenteral nutrition patients with a low infection rate?
    Olthof ED; Broekman MM; Wanten GJ
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385. PubMed ID: 25883235
    [No Abstract]   [Full Text] [Related]  

  • 48. Taurolidine lock - experience from the West of Scotland.
    Cullis PS; McKee RF
    Clin Nutr; 2011 Jun; 30(3):399-400; author reply 401. PubMed ID: 21256637
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pleural empyema and Tauroflex. Study of a new bactericidal agent].
    Marti MC; Moser G; Bordigoni P
    Schweiz Med Wochenschr; 1978 Feb; 108(6):215-6. PubMed ID: 341304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Infection of bones and joints].
    Burri C; Neugebauer R
    Aktuelle Probl Chir Orthop; 1989; 34():1-110. PubMed ID: 2564744
    [No Abstract]   [Full Text] [Related]  

  • 51. Early burn excision and systemic response to endotoxin.
    Monson JR; Donohue JH
    Surgery; 1991 Jul; 110(1):119-20. PubMed ID: 1866689
    [No Abstract]   [Full Text] [Related]  

  • 52. Taurolidine in Pediatric Home Parenteral Nutrition Patients.
    Hulshof EC; Hanff LM; Olieman J; de Vette S; Driessen GJ; Meeussen C; Escher JC
    Pediatr Infect Dis J; 2017 Feb; 36(2):233-235. PubMed ID: 27846059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of plaque growth with taurolin, vantocil and amine fluoride.
    Mühlemann HR; Strub JR
    Helv Odontol Acta; 1975 Oct; 19(2):57-60. PubMed ID: 773907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High performance liquid chromatography and preliminary pharmacokinetics of rufloxacin and its metabolites N-desmethylrufloxacin and rufloxacinsulfoxide in plasma and urine of humans.
    Vree TB; van den Biggelaar-Martea M; Imbimbo BP
    Eur J Drug Metab Pharmacokinet; 1992; 17(1):45-9. PubMed ID: 1323466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Taurolidine use as a Scolicidal Agent: We Need Different Methodologies.
    Teksöz S; Aytaç E
    Turkiye Parazitol Derg; 2012; 36(2):131-2. PubMed ID: 22801922
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of orofacial infections. Taurolidine--an alternative treatment concept to antimicrobial chemotherapy].
    Zimmermann M
    Fortschr Med; 1992 Oct; 110(29):543. PubMed ID: 1427551
    [No Abstract]   [Full Text] [Related]  

  • 57. Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial.
    Filiopoulos V; Hadjiyannakos D; Koutis I; Trompouki S; Micha T; Lazarou D; Vlassopoulos D
    Am J Nephrol; 2011; 33(3):260-8. PubMed ID: 21372561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Measurement of Meloxicam and Meloxicam Metabolites in Rat Plasma Using a High-Performance Liquid Chromatography-Ultraviolet Spectrophotometry Method.
    Miyamoto A; Aoyama T; Matsumoto Y
    Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):121-126. PubMed ID: 27904016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intraperitoneal and intravenous tauroflex, without antibiotics in the treatment of 40 cases of peritonitis (author's transl)].
    Moser G; Marti MC
    Schweiz Rundsch Med Prax; 1978 Mar; 67(12):425-8. PubMed ID: 643810
    [No Abstract]   [Full Text] [Related]  

  • 60. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
    Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
    Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.